ConductScience.org, home

Trial · NCT05491525

Registered outcomes15

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryChange from Baseline in maximum cystometric capacity (MCC) based on bladder filling urodynamicsOptimized Treatment Week 24
SecondaryChange from Baseline in MCCOptimized Week 12
SecondaryChange from Baseline in number of overactive detrusor contractions until the end of bladder fillingOptimized Treatment Weeks 12 and 24
SecondaryChange from Baseline in detrusor pressure at the end of bladder fillingOptimized Treatment Weeks 12 and 24
SecondaryChange from Baseline in bladder filling volume until first involuntary/hyperactive detrusor contractionOptimized Treatment Weeks 12 and 24
SecondaryChange from Baseline in bladder compliance (mL/cm H2O)Optimized Treatment Weeks 12 and 24Bladder compliance is calculated by dividing the change in volume by the change in detrusor pressure during the filling of the bladder
SecondaryChange from Baseline in average first morning catheterized volumethrough study completion, an average of 52 weeks
SecondaryChange from Baseline in average catheterized volume per catheterizationthrough study completion, an average of 52 weeks
SecondaryChange from Baseline in average maximum catheterized volume per daythrough study completion, an average of 52 weeks
SecondaryChange from Baseline in average maximum catheterized daytime volumethrough study completion, an average of 52 weeks
SecondaryChange from Baseline in average number of leakage episodes per daythrough study completion, an average of 52 weeks
SecondaryChange from Baseline in estimated number of dry (leakage-free) days/ 7 daysthrough study completion, an average of 52 weeks
SecondaryChange from Baseline in Pediatric Incontinence Questionnaire (PIN-Q)through study completion, an average of 52 weeks
PIN-Q is a 20-item questionnaire addressing quality of life for participants with bladder disorders. Each question was answered on a scale from 0 (no, never) to 4 (all the time). The total score ranged from 0 to 80, with higher scores indicating more impact on the quality of life.
SecondaryChange from Baseline in Patient Global Impression of Severity (PGI-S) Scalethrough study completion, an average of 52 weeksPGI-S is a 5 point scale that determines the bladder condition of a participant with 0 being really bad and 4 as really good. Higher score indicates better bladder condition.
SecondaryChange from Baseline in Clinical Global Impression of Change (CGI-C) Scalethrough study completion, an average of 52 weeks
The CGI-C scale is used to determine the degree of change in participant's overall bladder symptoms since the start of the study on Day 1. The scale will be filled by the investigator by ticking on any of the following options: very much improved, much improved, minimally improved, no change, minimally worse, much worse and very much worse.

Source ClinicalTrials.govtrials-2026-11-12-0.5.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT05491525/registered